Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionSterling Capital Management LLC
Latest Disclosed Ownership673 shares
Latest Disclosed Value $ 27,129
Sterling Capital Management LLC ownership in HTD / Corcept Therapeutics Incorporated

On April 22, 2026 - Sterling Capital Management LLC filed a 13F-HR form disclosing ownership of 673 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $23,212 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 673 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $42,561 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 673 0 0.00 27 17.39 0.0004
2026-02-13 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 673 530 370.63 23 109.09 0.0004
2025-11-12 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 143 -1 -0.69 12 10.00 0.0002
2025-08-08 2025-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 144 59 69.41 11 11.11 0.0002
2025-08-06 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 144 59 11 0.0002
2025-05-13 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 85 2 2.41 10 125.00 0.0002
2025-02-13 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 83 0 0.00 4 33.33 0.0001
2024-11-12 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 83 -82,812 -99.90 4 -99.74 0.0000
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 82,895 82,895 1,172 0.0111
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.